Studies on Platelet Aggregation before and after Carotid Endarterectomy (Part2) : Relationship between Coagulo-fibrinolytic Activities and Platelet Aggregation following Venous Occlusion Test

1995 ◽  
Vol 4 (4) ◽  
pp. 351-358
Author(s):  
Noboru Asano ◽  
Shin Ueda
1987 ◽  
Author(s):  
I Scharrer ◽  
V Hach-Wunderle ◽  
H Heyland ◽  
C Kuhn

The incidence of defective T-PA release in 158 young unrelated patients (<45 years old) with deep vein thrombosis was studied and compared to that of PC-, PS-, AT III-, fibrinogen- and plasminogen deficiency. Thrombotic episodes were documented using venography with contrast medium. Venous occlusion test (VO) over 20 min. was performed in all patients, 8-12 weeks after thrombosis. T-PA antigen (Biopool kit) , T-PA activity (on fibimplates) and PAI (T-PA-inhibitor, Biopool kit) were measured before and after VO in the fasting morning samples. Furthermore we investigated the functional and immunologic levels of PC,PS,AT III, fibrinogen and plasminogen. We detected 28 patients (15 females, 13 males)= 17.7% with abnormal T-PA release. In these patients the VO test was repeated three times in an interval of 6-8 weeks. Release of T-PA activity and T-PA-Ag was diminished in all these patients. PAI levels were enhanced in 12 of these 28 patients. The rate of recurrency of thrombosis was 52%. A family history of thrombosis was reported only in 20%The incidence of PC def. was 9.4%, of PS def. 6.3%, of AT III def 5%, of dysfibrinogenemia 0.6% and of plasminogen def. 1.2%. No combined defect of abnormal T-PA release with other known hereditary coagulation or fibrinolysis disorders could be detected.In 11 healthy volunteers we investigated 4 different time periods of VO, 5, 10, 15 and 20 min. in an interval of 10 days in order to find the suitable time for VO. It was striking that T-PA activity (on fibrin plates) did not decrease to the same extent as T-PA-Ag. The different behaviour is demonstrated on table 1. Decrease in % is compared to the values of 20 min. VO.


1995 ◽  
Vol 79 (4) ◽  
pp. 363-368 ◽  
Author(s):  
Bernhard Kempter ◽  
Alexander Peinemann ◽  
Oliver Biniasch ◽  
Roman L. Haberl

1990 ◽  
Vol 4 ◽  
pp. 65
Author(s):  
J.C. Gris ◽  
J.F. Schved ◽  
P. Martinez ◽  
A. Arnaud ◽  
N. Sanchez ◽  
...  

1995 ◽  
Vol 73 (03) ◽  
pp. 362-367 ◽  
Author(s):  
Jean-Christophe Gris ◽  
Sylvie Neveu ◽  
Marie-Laure Tailland ◽  
Christophe Courtieu ◽  
Pierre Marès ◽  
...  

SummaryAn impaired fibrinolytic capacity, defined as an insufficient venous occlusion-induced shortening of the plasma euglobulin clot lysis time, is a common feature in women suffering from primary early recurrent unexplained miscarriages (1,2). We investigated the therapeutic effect of a low-molecular-weight heparin and of a phenformin-like substance.In a prospective, randomized trial, 30 consecutive patients initially received either enoxaparin, 20 mg per day during one month, or moroxydine chloride, 1200 mg per day during one month. In case of fibrinolytic status normalization, they were treated during 6 months by the beneficial treatment which was planned to be continued during eventual pregnancies. Patients with hypofibrinolysis persistence received the alternative treatment during another month and a new evaluation was performed. No treatment was given when a persistent abnormal response to the venous occlusion test was evidenced. In case of positive response, the treatment was continued during 6 months. The primary study end-points consisted of any of the following: effect of the treatments on the fibrinolytic response; number of patients becoming pregnant during the 6 months following the last venous occlusion test; number of full-term pregnancies.Concerning the effects on the fibrinolytic system, 20 out of 29 women responded to the first or second-line enoxaparin treatment whereas only 1 woman out of 19 responded to moroxydine chloride (p=0.00002). Concerning the effects on fertility, responders to LMWH were more likely to initiate a new pregnancy than non-responders (16/20 vs 2/10, p=0.002). In patients conceiving, LMWH responders were more likely to obtain live births than nonresponders (13/16 vs. 0/2, p=0.02). The 9 women who had not responded to both treatments and the one who had responded to moroxydine chloride are still childless. Thirteen of the 20 previously childless women who had responded to enoxaparin had a successful pregnancy whilst taking the low-molecular weight heparin (p=0.0009).The low-molecular weight heparin enoxaparin was associated with successful pregnancies in patients with recurrent unexplained miscarriages associated with an impaired fibrinolytic capacity.


1985 ◽  
Vol 16 (1) ◽  
pp. 56-58
Author(s):  
Hirochika MENJO ◽  
Toshihiko BANNO ◽  
Yoshika AMANO ◽  
Masatoshi YAMAMOTO ◽  
Takashi OGURI ◽  
...  

1991 ◽  
Vol 62 (1-2) ◽  
pp. 83-92 ◽  
Author(s):  
A. Mizuno ◽  
J. Isobe ◽  
K. Shima

1993 ◽  
Vol 72 (4) ◽  
pp. 359-361
Author(s):  
J. Hladovec ◽  
Z. Sommerová ◽  
I. Přerovský

Sign in / Sign up

Export Citation Format

Share Document